Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9822675rdf:typepubmed:Citationlld:pubmed
pubmed-article:9822675lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:9822675lifeskim:mentionsumls-concept:C0214743lld:lifeskim
pubmed-article:9822675lifeskim:mentionsumls-concept:C1334291lld:lifeskim
pubmed-article:9822675lifeskim:mentionsumls-concept:C0026473lld:lifeskim
pubmed-article:9822675lifeskim:mentionsumls-concept:C0003692lld:lifeskim
pubmed-article:9822675lifeskim:mentionsumls-concept:C0017262lld:lifeskim
pubmed-article:9822675lifeskim:mentionsumls-concept:C1519726lld:lifeskim
pubmed-article:9822675lifeskim:mentionsumls-concept:C1421249lld:lifeskim
pubmed-article:9822675lifeskim:mentionsumls-concept:C0205263lld:lifeskim
pubmed-article:9822675lifeskim:mentionsumls-concept:C1546857lld:lifeskim
pubmed-article:9822675lifeskim:mentionsumls-concept:C2911684lld:lifeskim
pubmed-article:9822675lifeskim:mentionsumls-concept:C0185117lld:lifeskim
pubmed-article:9822675pubmed:issue48lld:pubmed
pubmed-article:9822675pubmed:dateCreated1998-12-23lld:pubmed
pubmed-article:9822675pubmed:abstractTextThe enzyme 15-lipoxygenase (15-LO) participates in the dioxygenation of polyenoic fatty acids. This activity leads to the degradation of mitochondrial membranes during reticulocyte differentiation, the production of pro- and anti-inflammatory mediators by a variety of cell types, and the oxidation of lipids in atherosclerotic lesions. The cytokines, IL-4 and IL-13, are reported to induce the expression of 15-LO in human peripheral blood monocytes. In this report we explore the signaling mechanisms involved in the IL-13-mediated induction of 15-LO expression. First we demonstrate that the delayed induction of 15-LO requires continuous stimulation of monocytes for a minimum period of 12 h. We also found that tyrosine kinase inhibitors blocked the induction of 15-LO in a dose-dependent manner. By immunoprecipitation and antiphosphotyrosine blotting experiments, IL-13 was shown to induce tyrosine phosphorylation of Jak2 and Tyk2, but not Jak1 or Jak3, within 5 min of treatment in human monocytes. To investigate whether the early induction of tyrosine phosphorylation of both Jak2 and Tyk2 was ultimately involved in 15-LO expression, we generated antisense oligodeoxyribonucleotides (ODNs) against Tyk2 and Jak2. We employed a cationic lipid-mediated delivery technique to transfect the monocytes and found that both antisense ODNs inhibited expression of their target proteins by 75-85%. The treatments were specific and did not affect the expression of each other. Furthermore, the antisense ODNs to Jak2 and Tyk2 both inhibited the induction of expression of 15-LO in monocytes treated with IL-13. Parallel experiments with sense ODNs to Jak2 and Tyk2 did not affect their protein levels or the induction of 15-LO by IL-13, and down-regulation of Jak1 also did not affect expression of 15-LO. Our results suggest the novel finding that IL-13 can induce tyrosine phosphorylation of both Jak2 and Tyk2 in primary human monocytes. This occurs as an early and essential signal transduction event for the IL-13-mediated induction of 15-LO expression. These data represent the first characterization of upstream kinases involved in the induced expression of 15-LO.lld:pubmed
pubmed-article:9822675pubmed:languageenglld:pubmed
pubmed-article:9822675pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9822675pubmed:citationSubsetIMlld:pubmed
pubmed-article:9822675pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9822675pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9822675pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9822675pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9822675pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9822675pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9822675pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9822675pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9822675pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9822675pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9822675pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9822675pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9822675pubmed:statusMEDLINElld:pubmed
pubmed-article:9822675pubmed:monthNovlld:pubmed
pubmed-article:9822675pubmed:issn0021-9258lld:pubmed
pubmed-article:9822675pubmed:authorpubmed-author:RoyBBlld:pubmed
pubmed-article:9822675pubmed:authorpubmed-author:CathcartM KMKlld:pubmed
pubmed-article:9822675pubmed:issnTypePrintlld:pubmed
pubmed-article:9822675pubmed:day27lld:pubmed
pubmed-article:9822675pubmed:volume273lld:pubmed
pubmed-article:9822675pubmed:ownerNLMlld:pubmed
pubmed-article:9822675pubmed:authorsCompleteYlld:pubmed
pubmed-article:9822675pubmed:pagination32023-9lld:pubmed
pubmed-article:9822675pubmed:dateRevised2009-11-19lld:pubmed
pubmed-article:9822675pubmed:meshHeadingpubmed-meshheading:9822675-...lld:pubmed
pubmed-article:9822675pubmed:meshHeadingpubmed-meshheading:9822675-...lld:pubmed
pubmed-article:9822675pubmed:meshHeadingpubmed-meshheading:9822675-...lld:pubmed
pubmed-article:9822675pubmed:meshHeadingpubmed-meshheading:9822675-...lld:pubmed
pubmed-article:9822675pubmed:meshHeadingpubmed-meshheading:9822675-...lld:pubmed
pubmed-article:9822675pubmed:meshHeadingpubmed-meshheading:9822675-...lld:pubmed
pubmed-article:9822675pubmed:meshHeadingpubmed-meshheading:9822675-...lld:pubmed
pubmed-article:9822675pubmed:meshHeadingpubmed-meshheading:9822675-...lld:pubmed
pubmed-article:9822675pubmed:meshHeadingpubmed-meshheading:9822675-...lld:pubmed
pubmed-article:9822675pubmed:meshHeadingpubmed-meshheading:9822675-...lld:pubmed
pubmed-article:9822675pubmed:meshHeadingpubmed-meshheading:9822675-...lld:pubmed
pubmed-article:9822675pubmed:meshHeadingpubmed-meshheading:9822675-...lld:pubmed
pubmed-article:9822675pubmed:meshHeadingpubmed-meshheading:9822675-...lld:pubmed
pubmed-article:9822675pubmed:meshHeadingpubmed-meshheading:9822675-...lld:pubmed
pubmed-article:9822675pubmed:meshHeadingpubmed-meshheading:9822675-...lld:pubmed
pubmed-article:9822675pubmed:meshHeadingpubmed-meshheading:9822675-...lld:pubmed
pubmed-article:9822675pubmed:meshHeadingpubmed-meshheading:9822675-...lld:pubmed
pubmed-article:9822675pubmed:year1998lld:pubmed
pubmed-article:9822675pubmed:articleTitleInduction of 15-lipoxygenase expression by IL-13 requires tyrosine phosphorylation of Jak2 and Tyk2 in human monocytes.lld:pubmed
pubmed-article:9822675pubmed:affiliationDepartment of Cell Biology, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA.lld:pubmed
pubmed-article:9822675pubmed:publicationTypeJournal Articlelld:pubmed
entrez-gene:246entrezgene:pubmedpubmed-article:9822675lld:entrezgene
entrez-gene:7297entrezgene:pubmedpubmed-article:9822675lld:entrezgene
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9822675lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9822675lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9822675lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9822675lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9822675lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9822675lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9822675lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9822675lld:pubmed